Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Clinical trial NCT04263870 · UNKNOWN

Trial details

NCT number: NCT04263870
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Junction Adenocarcinoma Stomach Adenocarcinoma Locally Advanced Unresectable Gastric Adenocarcinoma Metastatic Gastric Cancer

Start date: 2020-03-01
Primary completion: 2021-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.